Logo-bi
BioImpacts. 2022;12(5): 449-461. doi: 10.34172/bi.2022.23263
PMID: 36381633        PMCID: PMC9596881

Original Research

PEGylated nanohydrogels delivering anti-MicroRNA-21 suppress ovarian tumor-associated angiogenesis in matrigel and chicken chorioallantoic membrane models

Sanaz Javanmardi 1 ORCID, Samira Sadat Abolmaali 2 * ORCID, Mohammad Javad Mehrabanpour 3, Mahmoud Reza Aghamaali 1, Ali Mohammad Tamaddon 4

Cited by CrossRef: 4


1- Espuche B, Moya S, Calderón M. Nanogels: Smart tools to enlarge the therapeutic window of gene therapy. International Journal of Pharmaceutics. 2024;653:123864 [Crossref]
2- Sadat Abolmaali S, Zarenejad S, Mohebi Y, Najafi H, Javanmardi S, Abedi M, Mohammad Tamaddon A. Biotin receptor-targeting nanogels loaded with methotrexate for enhanced antitumor efficacy in triple-negative breast cancer in vitro and in vivo models. International Journal of Pharmaceutics. 2022;624:122049 [Crossref]
3- Maruf A, Milewska M, Lalik A, Student S, Wandzik I. A Simple Synthesis of Reduction-Responsive Acrylamide-Type Nanogels for miRNA Delivery. Molecules. 2023;28(2):761 [Crossref]
4- Palumbo C, Sisi F, Checchi M. CAM Model: Intriguing Natural Bioreactor for Sustainable Research and Reliable/Versatile Testing. Biology. 2023;12(9):1219 [Crossref]
5- Heidari M, Salmanpour M, Najafi H, Monajati M, Rahiminezhad Z, Azarpira N, Sadat Abolmaali S, Tamaddon A. Graphene Quantum Dot‐PEI‐Cyclodextrin Nanocarrier for Simultaneous miR21a Delivery and Cell Imaging in Cancer Therapy. ChemistrySelect. 2023;8(19) [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge